Colgate-Palmolive Company $CL Shares Sold by Atria Investments Inc

Atria Investments Inc decreased its stake in Colgate-Palmolive Company (NYSE:CL) by 17.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 54,227 shares of the company’s stock after selling 11,616 shares during the quarter. Atria Investments Inc’s holdings in Colgate-Palmolive were worth $4,929,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of CL. Brighton Jones LLC boosted its position in Colgate-Palmolive by 4.4% during the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after acquiring an additional 450 shares during the last quarter. Avantax Planning Partners Inc. boosted its position in Colgate-Palmolive by 7.5% during the first quarter. Avantax Planning Partners Inc. now owns 5,407 shares of the company’s stock worth $507,000 after acquiring an additional 378 shares during the last quarter. Harel Insurance Investments & Financial Services Ltd. acquired a new position in Colgate-Palmolive during the first quarter worth about $37,000. Catalyst Capital Advisors LLC boosted its position in Colgate-Palmolive by 45.2% during the first quarter. Catalyst Capital Advisors LLC now owns 1,580 shares of the company’s stock worth $148,000 after acquiring an additional 492 shares during the last quarter. Finally, Brookstone Capital Management boosted its position in Colgate-Palmolive by 508.8% during the first quarter. Brookstone Capital Management now owns 118,439 shares of the company’s stock worth $11,098,000 after acquiring an additional 98,984 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on CL shares. Bank of America lowered their price target on shares of Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Barclays lowered their price target on shares of Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 1st. Citigroup lowered their price target on shares of Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating on the stock in a research report on Monday, August 4th. Weiss Ratings reiterated a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, October 8th. Finally, UBS Group decreased their target price on shares of Colgate-Palmolive from $99.00 to $92.00 and set a “buy” rating on the stock in a report on Wednesday, October 8th. Eight investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $91.50.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $77.10 on Friday. The company’s 50-day moving average is $80.45 and its two-hundred day moving average is $86.33. The firm has a market capitalization of $62.32 billion, a price-to-earnings ratio of 21.66, a PEG ratio of 4.44 and a beta of 0.34. Colgate-Palmolive Company has a 1-year low of $74.62 and a 1-year high of $100.18. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.02. The business had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.17 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The business’s revenue was up 1.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.91 EPS. Analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date of this dividend is Friday, October 17th. Colgate-Palmolive’s payout ratio is 58.43%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.